Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[New results in the management of hypercholesterolemia]

Beatrix Sármán1

  • 1Semmelweis Egyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika, Budapest. sarbea@bel2.sote.hu

Orvosi Hetilap
|November 4, 2005
PubMed

Insights

New research shows lowering low-density lipoprotein cholesterol (LDL-C) and targeting inflammation can further reduce cardiovascular disease risk. Novel therapies offer improved cholesterol management for high-risk patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Context:

  • Cardiovascular disease (CVD) remains a leading global cause of death.
  • Established links exist between serum lipid levels and coronary heart disease (CHD) development.
  • National Cholesterol Education Program guidelines provide a framework for cholesterol management.

Purpose:

  • To review recent clinical trials and experimental findings on cholesterol-lowering therapies.
  • To discuss the impact of new evidence on managing dyslipidemia and cardiovascular risk.
  • To highlight emerging antilipemic agents and their therapeutic potential.

Summary:

  • Recent trials suggest lowering low-density lipoprotein cholesterol (LDL-C) below 2.6 mmol/l offers additional cardiovascular risk reduction in high-risk individuals.
  • Inflammation, indicated by elevated C-reactive protein (CRP), is increasingly recognized as an independent cardiovascular risk factor.
  • Statin therapy demonstrates enhanced efficacy in patients with high CRP levels. Ezetimibe, an intestinal cholesterol absorption inhibitor, offers another treatment option, alone or with statins.

Impact:

  • These findings necessitate updated approaches to cholesterol management, particularly for high-risk populations.
  • The integration of inflammation markers like CRP into risk assessment may refine treatment strategies.
  • Emerging antilipemic agents promise to expand therapeutic options for achieving optimal lipid goals and reducing cardiovascular events.

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...